Overview

Safety and Efficacy of Nebivolol in the Treatment of Hypertension in African Americans

Status:
Completed
Trial end date:
2007-09-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the effects of nebivolol on blood pressure and heart rate in African American patients with hypertension.
Phase:
Phase 3
Details
Lead Sponsor:
Mylan Bertek Pharmaceuticals
Treatments:
Atenolol
Nebivolol